Search Results - Carlos Camps
- Showing 1 - 20 results of 42
- Go to Next Page
-
1
-
2
-
3
-
4
Individual Patient Data Meta-Analysis of Docetaxel Administered Once Every 3 Weeks Compared With Once Every Week Second-Line Treatment of Advanced Non–Small-Cell Lung Cancer by Massimo Di Maïo, Francesco Perrone, Paolo Chiodini, Ciro Gallo, Carlos Camps, Wolfgang Schuette, Élisabeth Quoix, Chun-Ming Tsai, Cesare Gridelli
Published 2007Revisão -
5
microRNA-Associated Progression Pathways and Potential Therapeutic Targets Identified by Integrated mRNA and microRNA Expression Profiling in Breast Cancer by Francesca M. Buffa, Carlos Camps, Laura Winchester, Cameron Snell, Harriet E. Gee, Helen Sheldon, Marian Taylor, Adrian L. Harris, Jiannis Ragoussis
Published 2011Artigo -
6
The Role of Tumor Stroma in Cancer Progression and Prognosis: Emphasis on Carcinoma-Associated Fibroblasts and Non-small Cell Lung Cancer by Roy M. Bremnes, Tom Dønnem, Samer Al‐Saad, Khalid Al‐Shibli, Sigve Andersen, Rafael Sirera, Carlos Camps, Inigo Marinez, Lill‐Tove Busund
Published 2010Revisão -
7
The Role of Tumor-Infiltrating Immune Cells and Chronic Inflammation at the Tumor Site on Cancer Development, Progression, and Prognosis: Emphasis on Non-small Cell Lung Cancer by Roy M. Bremnes, Khalid Al‐Shibli, Tom Dønnem, Rafael Sirera, Samer Al‐Saad, Sigve Andersen, Helge Stenvold, Carlos Camps, Lill‐Tove Busund
Published 2010Revisão -
8
-
9
Ribonucleotide Reductase Messenger RNA Expression and Survival in Gemcitabine/Cisplatin-Treated Advanced Non-Small Cell Lung Cancer Patients by Rafael Rosell, Kathleen D. Danenberg, V. Alberola, Gerold Bepler, José Javier Sánchez, Carlos Camps, Mariano Provencio, Dolores Isla, Miquel Tarón, Pilar Díz, Á. Artal
Published 2004Artigo -
10
Cannabinoid receptor expression in non-small cell lung cancer. Effectiveness of tetrahydrocannabinol and cannabidiol inhibiting cell proliferation and epithelial-mesenchymal transi... by Lara Milián, Manuel Mata, Javier Alcácer, María Oliver-Ferrándiz, María Sancho‐Tello, José Javier Martı́n de Llano, Carlos Camps, José M. Galbis, Julián Carretero, Carmen Cardá
Published 2020Artigo -
11
Serum metabolomic profiling facilitates the non-invasive identification of metabolic biomarkers associated with the onset and progression of non-small cell lung cancer by Leonor Puchades‐Carrasco, Eloísa Jantus‐Lewintre, Clara Pérez-Rambla, Francisco García‐García, Rut Lucas-Domínguez, Silvia Calabuig‐Fariñas, Ana Blasco, Joaquı́n Dopazo, Carlos Camps, Antonio Pineda‐Lucena
Published 2016Artigo -
12
Gene panel sequencing improves the diagnostic work-up of patients with idiopathic erythrocytosis and identifies new mutations by Carlos Camps, Nayia Petousi, Celeste Bento, Holger Cario, Richard R. Copley, Mary Frances McMullin, Richard van Wijk, Peter J. Ratcliffe, Peter A. Robbins, Jenny C. Taylor
Published 2016Artigo -
13
Refining the role of pegfilgrastim (a long-acting G-CSF) for prevention of chemotherapy-induced febrile neutropenia: consensus guidance recommendations by Matti Aapro, Ralph V. Boccia, Robert Leonard, Carlos Camps, Mario Campone, Sylvain Choquet, Marco Danova, John A. Glaspy, Iwona Hus, Hartmut Link, Thamer Sliwa, Hans Tesch, Vicente Valero
Published 2017Revisão -
14
Update on systemic treatment in early triple negative breast cancer by M. Nunez Abad, Silvia Calabuig‐Fariñas, M. Lobo de Mena, María José Godes Sanz de Bremond, Clara García González, Susana Torres, José Ángel García, Vega Iranzo, Carlos Camps Herrero
Published 2021Revisão -
15
Circulating DNA is a Useful Prognostic Factor in Patients with Advanced Non-small Cell Lung Cancer by Rafael Sirera, Roy M. Bremnes, Andrea Cabrera‐Pastor, Eloísa Jantus‐Lewintre, Elena Sanmartín, Ana Blasco, Nieves del Pozo, Rafael Rosell, Ricardo Guijarro, José M. Galbis, José Javier Sánchez, Carlos Camps
Published 2011Artigo -
16
The small-nucleolar RNAs commonly used for microRNA normalisation correlate with tumour pathology and prognosis by Harriet E. Gee, Francesca M. Buffa, Carlos Camps, Anassuya Ramachandran, Russell Leek, M Taylor, Meena Patil, Helen Sheldon, Guy Betts, Jarrod J. Homer, Catharine West, Jiannis Ragoussis, Adrian L. Harris
Published 2011Artigo -
17
Impact of DLK1-DIO3 imprinted cluster hypomethylation in smoker patients with lung cancer by Sonia Molina‐Pinelo, Ana Salinas, Nicolás Moreno‐Mata, Irene Ferrer, Rocío Suárez, Eduardo Andrés‐León, Manuel Rodríguez‐Paredes, Julian Gutekunst, Eloísa Jantus‐Lewintre, Carlos Camps, Amancio Carnero, Luis Paz‐Ares
Published 2016Artigo -
18
Multicenter In-House Evaluation of an Amplicon-Based Next−Generation Sequencing Panel for Comprehensive Molecular Profiling by Eloísa Jantus‐Lewintre, Alessandra Rappa, Dina Ruano, Demi van Egmond, Sandra Gallach, Dilce Gozuyasli, Cecília Durães, José Luís Costa, Carlos Camps, Ludovic Lacroix, Karl Kashofer, Tom van Wezel, Massimo Barberis
Published 2025Artigo -
19
A Randomized Trial Comparing Preoperative Chemotherapy Plus Surgery with Surgery Alone in Patients with Non-Small-Cell Lung Cancer by R. Rosell, José Gómez‐Codina, Carlos Camps, J Maestre, Jose Padille, Antonio Cantó, José Luís Mate, Shanrong Li, Jorge Roig, Ángel Olazábal, Mercedes Canela, Aurelio Ariza, Z Skácel, Jose Morera-Prat, Albert Abad
Published 1994Artigo -
20
Analysis of the immune microenvironment in resected non-small cell lung cancer: the prognostic value of different T lymphocyte markers by Marta Usó, Eloísa Jantus‐Lewintre, Roy M. Bremnes, Silvia Calabuig‐Fariñas, Ana Blasco, Enrique Carbonell Pastor, Irene Borredá, Sonia Molina‐Pinelo, Luis Paz‐Ares, Ricardo Guijarro, Miguel Martorell, Jerónimo Forteza, Carlos Camps, Rafael Sirera
Published 2016Artigo
Search Tools:
Related Subjects
Medicine
Internal medicine
Biology
Oncology
Cancer
Lung cancer
Gene
Genetics
Cancer research
Chemotherapy
Pathology
Biochemistry
Bioinformatics
Surgery
Breast cancer
Confidence interval
Docetaxel
Gastroenterology
Hazard ratio
Paleontology
Cisplatin
Clinical trial
Computational biology
DNA repair
Disease
ERCC1
Genotype
Metastasis
Mutation
Nucleotide excision repair